Table 3.
Operative data
| Variables | Entire cohort (n=17) |
>1-year-old TAVR (n=5) |
<1-year-old TAVR (n=12) |
p- value |
|---|---|---|---|---|
| STS-PROM* (IQR) | 9.9 (6.2-21.4) | 17.6 (7.9-53.3) | 9.24 (5.6-20.1) | 0.21 |
| STS-PROM with incremental risk factors* (IQR) | 16.6 (12.3-33.5) | 39.6 (12.4-62.3) | 14.7 (12.2-23.6) | 0.25 |
| Redo sternotomy | 8 (47.1) | 2 (40.0) | 6 (50.0) | 1.00 |
| First time redo | 7 (41.2) | 2 (40.0) | 5 (41.7) | |
| Second time redo | 1 (5.9) | 0 (20.0) | 1 (8.3) | |
| TAVR device explanted | ||||
| CoreValve | 4 (23.5) | 2 (40.0) | 2 (16.7) | 0.54 |
| Evolut R | 6 (35.3) | 2 (40.0) | 4 (33.3) | 1.00 |
| Evolut PRO | 3 (17.6) | 0 | 3 (25.0) | 0.52 |
| Sapien | 1 (5.9) | 1 (20.0) | 1 (8.3) | 0.52 |
| Sapien 3 | 3 (17.6) | 0 | 3 (25.0) | 0.52 |
| TAVR valve age (Days) | 195 (69-486) | 1135 (438-2150) | 72 (59-170) | 0.001 |
| Cardiopulmonary bypass time (minutes) | 184 (138-246) | 202 (160-205) | 162 (134-302) | 0.92 |
| Aortic cross-clamp time (minutes) | 137 (91-188) | 173 (123-175) | 126 (85-226) | 0.75 |
| Circulatory arrest | 1 (5.9) | 0 | 1 (8.3) | 1.00 |
| Valve size (mm) | 25 (23-27) | 23 (21-24) | 25 (25-27) | 0.011 |
| Implanted valve | ||||
| Magna Ease | 9 (52.9) | 5 (100) | 9 (33.3) | 0.52 |
| Trifecta | 5 (29.4) | 0 | 5 (41.7) | 0.25 |
| Freestyle | 2 (11.8) | 0 | 2 (16.7) | 1.00 |
| St Jude Regent | 1 (5.9) | 0 | 1 (8.3) | 1.00 |
| Concomitant procedure(s) | ||||
| Root enlargement | 3 (17.6) | 2 (40.0) | 1 (8.3) | 0.19 |
| Mitral | 4 (23.5) | 2 (40.0) | 2 (16.6) | 0.55 |
| Tricuspid | 3 (17.6) | 1 (20.0) | 2 (16.6) | 1.00 |
| Mitral + Tricuspid | 2 (11.8) | 1 (20.0) | 1 (8.3) | 0.52 |
| Aortic surgery | 6 (35.3) | 5 (100) | 1 (8.3) | 0.001 |
| Ascending | 1 (5.9) | 1 (20.0) | 1 (8.3) | 0.52 |
| Partial arch | 1 (5.9) | 0 | 1 (8.3) | 1.00 |
| Root | 2 (11.8) | 1 (20.0) | 1 (8.3) | 0.52 |
| Endarterectomy | 5 (29.4) | 5 (100) | 0 | <0.001 |
| Root patch repair | 1 (5.9) | 1 (20.0) | 0 | 0.29 |
| CABG | 1 (5.9) | 1 (20.0) | 1 (8.3) | 0.29 |
| ECMO | 2 (11.8) | 1 (20.0) | 1 (8.3) | 0.52 |
| IABP | 2 (11.8) | 0 | 2 (16.7) | 1.00 |
Bold indicates statistically significant (p<0.05).
*
The median of the Calculated using STS Adult Cardiac Surgery Database Version 2.9 only for isolated AVR or AVR + CABG despite multiple other concurrent procedures in some patients.
STS-PROM, Society of Thoracic Surgeons Predicted Risk of Mortality; IQR, interquartile range; CABG, coronary artery bypass grafting; TAVR, transcatheter aortic valve replacement; AVR, aortic valve replacement; ECMO, extracorporeal membrane oxygenation; IABP, intraaortic balloon pumping